Full detailed real human like all aspects prescription for pain in abdomen in rt side with usg showing 6mm renal calculi in rt side and also burning micturition and increased frequency 45 year female patient
Reading File
Finding Sources
Finding Sources
Finding Sources
Searching the Web
renal calculi 6mm treatment management guidelines analgesic alpha blocker 2024
Finding Sources
Finding Sources
Searching PubMed
ureteral calculi medical expulsive therapy alpha blocker
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Now I have comprehensive information to write the detailed prescription. Let me compile everything into a complete, real-world clinical prescription.
Out-Patient Prescription
Date: 14/07/2026
Patient Name: Mrs. [Name]
Age / Sex: 45 Years / Female
Wt: ______ kg
Address: ______________________
Reg. No.: ______________________
Diagnosis
- Right renal calculus - 6 mm (USG-confirmed, right kidney)
- Right ureteric colic with partial obstruction
- Lower urinary tract symptoms (LUTS) - Burning micturition + increased frequency (likely associated UTI / urethral irritation secondary to stone)
Investigations Advised
| # | Investigation | Purpose |
|---|---|---|
| 1 | Urine Routine & Microscopy | Confirm UTI, hematuria, pyuria, crystals |
| 2 | Urine Culture & Sensitivity (C/S) | Identify organism, guide antibiotic |
| 3 | CBC (Complete Blood Count) | Leukocytosis, anemia |
| 4 | RFT (S. Creatinine, BUN, eGFR) | Assess renal function |
| 5 | Serum Electrolytes (Na+, K+, Ca2+) | Hypercalcemia screening, baseline |
| 6 | Serum Uric Acid | Rule out uric acid stone |
| 7 | X-ray KUB (Plain) | Radiopaque stone visibility |
| 8 | NCCT KUB (if not done) | Gold standard - stone size, location, HU density, hydronephrosis |
| 9 | 24-hr urine oxalate, calcium, citrate | After acute episode - metabolic workup |
Prescription (Rx)
Tab. Tamsulosin 0.4 mg (Alpha-1 Blocker - MET)
1 tablet at night after dinner
Duration: 4 weeks
(Medical Expulsive Therapy - relaxes ureteric smooth muscle, facilitates stone passage. Recommended by both AUA and EAU for stones 5-10 mm. Cochrane review [PMID: 36556996] confirms alpha blockers increase stone clearance and shorten expulsion time for stones >5 mm)
Tab. Diclofenac Sodium 50 mg + Serratiopeptidase 10 mg
(Or: Tab. Aceclofenac 100 mg + Paracetamol 325 mg)
1 tablet twice daily (morning & evening) after food
Duration: 5 days (for acute colic phase)
(NSAID is first-line analgesic for renal colic - reduces renal pelvic pressure, prostaglandin-mediated peristalsis. Brenner & Rector's: "NSAIDs, opioids, hydration, and antiemetics" form supportive care for colic)
Note: Avoid if serum creatinine is elevated or patient has NSAID intolerance.
Tab. Hyoscine Butylbromide (Buscopan) 10 mg
(Antispasmodic)
1 tablet three times daily before meals
Duration: 5-7 days
(Reduces ureteric spasm, relieves colicky pain)
Tab. Tramadol 50 mg + Paracetamol 325 mg
(Rescue Analgesic - use ONLY if pain is severe/uncontrolled by above)
1 tablet SOS (as needed), max 2 times in 24 hours
Duration: 3 days (for breakthrough pain only)
Cap. Nitrofurantoin 100 mg (Modified Release)
(For burning micturition / suspected UTI)
1 capsule twice daily after food
Duration: 5 days
(Appropriate first-line for uncomplicated lower UTI in women pending culture. Review and change as per urine C/S report)
Alternative if Nitrofurantoin unavailable: Tab. Norfloxacin 400 mg twice daily x 5 days OR Tab. Trimethoprim-Sulfamethoxazole (Co-trimoxazole DS) 1 tablet twice daily x 5 days
Tab. Ondansetron 4 mg (Antiemetic)
(For nausea / vomiting associated with colic)
1 tablet twice daily (morning & night) or SOS
Duration: 3-5 days
Tab. Potassium Citrate / Uralyt-U Granules
(Urine alkalinization - aids dissolution if uric acid component, reduces crystal aggregation)
1 sachet dissolved in water 3 times daily after meals
Duration: 4 weeks
(Target urine pH 6.5-7.0. Avoid if patient has hyperkalemia)
Tab. Vitamin B6 (Pyridoxine) 40 mg
1 tablet once daily
Duration: 4 weeks
(Reduces endogenous oxalate production - useful if oxalate stones suspected)
Advice / Instructions to Patient
-
Fluid intake - most important! Drink 3-4 litres of water per day (target urine output >2.5 L/day). This is the single most effective measure to aid stone passage and prevent new stone formation. - Brenner & Rector's, p. 1735
-
Strain urine - Patient should urinate through a fine sieve/strainer or clean cloth to collect the stone if it passes. Bring it for analysis (stone composition).
-
Diet modifications:
- Reduce salt (sodium) intake - less than 5 g/day
- Reduce animal protein (red meat, eggs)
- Limit oxalate-rich foods: spinach, nuts, chocolate, tea
- Increase citrate intake: lemon water, orange juice (not grapefruit)
- Do NOT drastically reduce dairy calcium (paradoxically increases oxalate absorption)
-
Physical activity: Mild walking/activity may help stone descent. Avoid complete bed rest.
-
Pain monitoring: If pain becomes severe, colicky, persistent > 2 hours, or associated with fever (>38.5°C), chills, rigor, decreased urine output, or vomiting - go to emergency immediately. These are warning signs of infected hydronephrosis / urosepsis requiring urgent intervention.
-
Follow-up in 2 weeks with urine culture report and USG KUB for stone position tracking. If stone does not pass in 4-6 weeks, or if any obstruction/infection is confirmed on imaging - urology referral for ESWL / Ureteroscopy (URS) + laser lithotripsy.
Referral Criteria (to Urology)
Refer urgently if any of the following:
- Fever with stone (infected hydronephrosis - urological emergency)
- Rising creatinine / obstructive uropathy
- Stone fails to pass after 4-6 weeks of conservative management
- Stone size progresses or causes significant hydronephrosis
- Solitary kidney with obstruction
Follow-Up Plan
| Visit | When | Purpose |
|---|---|---|
| Follow-Up 1 | 5-7 days | Urine C/S report review, antibiotic adjustment, pain control reassessment |
| Follow-Up 2 | 2 weeks | USG KUB for stone position, repeat urine routine |
| Follow-Up 3 | 4-6 weeks | Assess stone passage; if not passed - urology referral for intervention |
| Metabolic workup | After 6 weeks (stone-free interval) | 24-hr urine, serum calcium, uric acid - to prevent recurrence |
Clinical Notes
- A 6 mm stone falls at the boundary of expected spontaneous passage. Stones <4 mm pass in ~55% of cases; 4-6 mm in ~35%; >6 mm only ~8% (Brenner & Rector's The Kidney, p. 1734). Conservative management with MET is appropriate as a first step, but urological intervention should be planned if no passage in 4-6 weeks.
- Tamsulosin 0.4 mg is strongly supported by current evidence as MET - a 2022 systematic review and meta-analysis (PMID: 36556996) confirmed alpha blockers significantly increase stone clearance vs. placebo; silodosin and tamsulosin are comparable.
- Burning micturition + frequency in the context of a right renal calculus can be secondary to the stone itself (irritation) or a co-existing UTI. Empiric antibiotic therapy is started; definitive therapy based on urine culture.
- NSAIDs are preferred over opioids for renal colic as they address the prostaglandin-driven mechanism (reduce renal pelvic pressure). - Brenner & Rector's, p. 1073
- In a 45-year-old premenopausal female, hypercalciuria/hormonal factors should be evaluated once the acute episode resolves.
Dr. [Name]
MBBS, MD (Medicine) / MS (Surgery)
Reg. No.: __________
Clinic: ______________
Contact: ______________
Date: 14/07/2026
Next Visit: ________________
Signature & Stamp
Disclaimer: This prescription is based on clinical guidelines (AUA, EAU), Brenner & Rector's The Kidney (Comprehensive Nephrology), and current peer-reviewed evidence. Actual prescribing must be done by a licensed physician with full clinical assessment of the individual patient.
Tamsulosin in female???
Finding Sources
Searching PubMed
tamsulosin female ureteral stone medical expulsive therapy
Reading Article
PMID: 30694932
Reading Article
PMID: 29913020
Excellent question and fully evidence-backed. Here is the complete clarification:
Tamsulosin in Females - Is It Valid?
YES - It Is Established, Evidence-Based Practice
The concern is understandable because tamsulosin's primary licensed indication is BPH (benign prostatic hyperplasia) - an exclusively male condition. However, its use in MET for ureteral calculi is NOT sex-specific. Here's why:
The Mechanism Has Nothing to Do With the Prostate
Tamsulosin is a selective alpha-1A adrenergic receptor blocker. In the context of stone expulsion, it works on the ureter - specifically:
- Alpha-1 receptors are densely expressed in the distal ureter in both males and females
- It relaxes ureteric smooth muscle
- Reduces the frequency and amplitude of peristaltic contractions
- Decreases intraureteric pressure distal to the stone
- Allows passive stone descent and passage
The ureter is present in both sexes. The receptor distribution is the same. The pharmacology is identical.
What the Evidence Shows
Key meta-analysis (PMID: 30694932, J Urol 2019):
- 56 RCTs, 9,395 patients - included both males and females (MeSH terms: Female + Male)
- Tamsulosin: stone expulsion rate RR 1.44 (95% CI 1.35-1.55, p<0.01)
- Shorter expulsion time, fewer colic episodes, less need for intervention
- Significant benefit for stones >5 mm (our patient has a 6 mm stone - fits perfectly)
- Side effects not significantly different from placebo
Important counterpoint (PMID: 29913020, JAMA Intern Med 2018):
- 512 patients (27% female), stones mean 3.8 mm
- Tamsulosin did NOT significantly improve passage vs. placebo
- However - critically - most stones were small (<4 mm) where spontaneous passage rates are already very high (~55%), so any benefit would be hard to detect
- This study does NOT negate tamsulosin for larger stones (5-10 mm)
Bottom line from current guidelines (AUA & EAU):
- Alpha blockers (tamsulosin 0.4 mg) recommended for stones 5-10 mm in the distal ureter
- Recommendation applies to both sexes
- Our patient: 6 mm stone - squarely in the zone where tamsulosin has evidence
Side Effect Profile in Females
In males, the classic concern with tamsulosin is retrograde ejaculation - obviously irrelevant in females.
The relevant side effects in females are:
| Side Effect | Frequency | Clinical relevance |
|---|---|---|
| Orthostatic hypotension / dizziness | ~5-10% | Take at bedtime, rise slowly |
| Headache | Uncommon | Usually mild |
| Asthenia / fatigue | Uncommon | Transient |
| Rhinitis | Rare | Mild |
| Retrograde ejaculation | NOT applicable | Female patient |
In practice, tamsulosin is better tolerated in females than in males (no ejaculatory dysfunction).
Alternative if Tamsulosin Is Declined or Not Available
If you prefer, you can substitute:
| Drug | Dose | Notes |
|---|---|---|
| Silodosin 8 mg | Once daily at night | More uro-selective (alpha-1A), comparable or slightly superior MET efficacy per recent meta-analyses; also off-label for MET but increasingly used |
| Nifedipine 30 mg SR | Once daily | Calcium channel blocker, older alternative, weaker data vs. tamsulosin |
| Doxazosin 4 mg | Once daily | Less uretero-selective, more hypotension risk |
Silodosin and tamsulosin have been directly compared in a 2022 systematic review (PMID: 36556996) and show comparable efficacy - both are valid choices.
Summary
Tamsulosin 0.4 mg OD at bedtime is correct, appropriate, and evidence-supported for a 45-year-old female with a 6 mm right ureteral calculus. The drug label's indication for BPH does not restrict its off-label (and widely accepted) use in MET. Both AUA and EAU guidelines recommend it without sex restriction for stones 5-10 mm. Prescribe it with confidence, counsel about dizziness, and advise the patient to take it at night.
This is a shared conversation. Sign in to Orris to start your own chat.